What is this medicine used for?
FDA-approved uses
- Adjunctive treatment of parkinsonism and selected drug-induced extrapyramidal movement disorders — Patients selected according to product labeling and movement diagnosis. Drug-induced parkinsonism and selected dystonic reactions must be distinguished from tardive dyskinesiaTardive dyskinesiaTardive dyskinesia is a movement disorder that can develop after exposure to certain medicines, particularly antipsychotics. It causes repeated movements that the person does not intend, such as lip-smacking, chewing motions or tongue movements; other body areas can be affected.The movements may persist after the medicine is stopped. Report new involuntary movements to your prescriber; medication changes should be planned with them. and akathisiaAkathisiaAkathisia is distressing inner restlessness with a strong urge to move, sometimes caused by medication. It may lead to pacing, rocking or difficulty sitting still.Anxiety involves fear or worry; agitation is a broader state of distress or restlessness. These can overlap with akathisia, but the compelling urge to move is an important clue. Tell your prescriber promptly about new or worsening restlessness so the cause can be assessed.. This is not approval to treat an underlying psychiatric diagnosis.Benztropine mesylate tablets; Benztropine mesylate injection.
What should I expect?
Benefit depends on identifying the movement problem correctly. Benztropine can help some stiffness, shaking or acute muscle spasms caused by medication, but does not treat every abnormal movement.
Reassess the movement symptoms and ongoing need, along with memory, bowel and bladder function. Increasing the dose is not the right response to movements that may be tardive dyskinesiaTardive dyskinesiaTardive dyskinesia is a movement disorder that can develop after exposure to certain medicines, particularly antipsychotics. It causes repeated movements that the person does not intend, such as lip-smacking, chewing motions or tongue movements; other body areas can be affected.The movements may persist after the medicine is stopped. Report new involuntary movements to your prescriber; medication changes should be planned with them..
How do I take it safely?
Follow the oral prescription; injectable benztropine is administered by a clinician. The dose and duration depend on the specific movement problem. It is not a treatment for tardive dyskinesiaTardive dyskinesiaTardive dyskinesia is a movement disorder that can develop after exposure to certain medicines, particularly antipsychotics. It causes repeated movements that the person does not intend, such as lip-smacking, chewing motions or tongue movements; other body areas can be affected.The movements may persist after the medicine is stopped. Report new involuntary movements to your prescriber; medication changes should be planned with them. and can worsen it.
Follow memory, vision, bowel and bladder function, sweating and heat tolerance. Avoid overheating and driving when thinking or vision is affected. Other anticholinergic medicines, including some allergy or sleep products, and alcohol or sedatives can add adverse effects.
Glaucoma, urinary obstruction and bowel problems need assessment. Children younger than 3 must not receive it under the selected label, and older adults are particularly prone to confusion and retention. Pregnancy and breastfeeding safety are not established.
Review whether ongoing treatment is needed and plan stopping with the clinician. For a missed dose, take it when remembered unless the next is near; never double.
Existing psychosisPsychosisPsychosis describes symptoms that affect a person’s ability to tell what is real. These can include hallucinations, delusions and disorganized thinking or speech.Psychosis can occur with different mental or physical health conditions, some medicines or substance use. It does not automatically mean schizophrenia. New symptoms need prompt professional assessment. or memory impairment needs particular caution.
Do not use this product after a known allergy to its active medicine or ingredients; tell the pharmacist about previous medication reactions.
What side effects should I know about?
- Dry mouth, constipation, blurred vision, nausea and dizziness.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)BENZTROPINE MESYLATE- benztropine mesylate tablet
- View FDA Prescribing Information (PDF) (opens in a new tab)BENZTROPINE MESYLATE- benztropine mesylate injection
Which warning signs need help?
- Overheating with little sweating, severe confusion, high fever or collapse can be an emergency. Suspected overdose requires immediate emergency assessment.
- Inability to urinate, sudden painful vision changes or a swollen painful abdomen needs urgent assessment. Fever with rigidity and altered awareness may be neuroleptic malignant syndrome; taking more benztropine is not its treatment.
- Tardive dyskinesiaTardive dyskinesiaTardive dyskinesia is a movement disorder that can develop after exposure to certain medicines, particularly antipsychotics. It causes repeated movements that the person does not intend, such as lip-smacking, chewing motions or tongue movements; other body areas can be affected.The movements may persist after the medicine is stopped. Report new involuntary movements to your prescriber; medication changes should be planned with them. can worsen. Report new or changing involuntary movements rather than increasing the dose yourself.
What else should I know to stay safe?
- Do not use after product allergy or in children younger than 3. Older children also need caution because of the medicine’s effects on sweating, alertness and other body functions. Older age, memory problems, psychosisPsychosisPsychosis describes symptoms that affect a person’s ability to tell what is real. These can include hallucinations, delusions and disorganized thinking or speech.Psychosis can occur with different mental or physical health conditions, some medicines or substance use. It does not automatically mean schizophrenia. New symptoms need prompt professional assessment., glaucoma risk, bowel or urinary obstruction require particular caution.
- Monitor memory, vision, bowel and bladder function and heat tolerance. Other anticholinergic medicines, including some sleep or allergy products, and alcohol or sedatives can add harm. Avoid overheating and driving when thinking or vision is affected.
- Review continuing need and plan stopping with the clinician. Discuss pregnancy and breastfeeding because safety is not established.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- Different movement side effects need different treatments. Benztropine can worsen tardive dyskinesiaTardive dyskinesiaTardive dyskinesia is a movement disorder that can develop after exposure to certain medicines, particularly antipsychotics. It causes repeated movements that the person does not intend, such as lip-smacking, chewing motions or tongue movements; other body areas can be affected.The movements may persist after the medicine is stopped. Report new involuntary movements to your prescriber; medication changes should be planned with them., even though it helps some other antipsychotic-related movement problems.
- Dry mouth, constipation and thinking problems can add up across medicines, including nonprescription sleep or allergy products.
How does it work?
Benztropine reduces the effect of acetylcholine, a chemical messenger involved in movement and many other body functions. This can help with certain movement problems, including stiffness and shaking. It changes how cells respond to a message; it does not replace dopamine, another messenger involved in movement, or cure the underlying condition.
Explore more in Brain & Science: What Receptors and Transporters Do.
How was this medicine developed?
The original Cogentin tablet application was approved in 1954. Benztropine entered psychiatric practice for selected movement effects of other medicines, rather than as a treatment for psychosisPsychosisPsychosis describes symptoms that affect a person’s ability to tell what is real. These can include hallucinations, delusions and disorganized thinking or speech.Psychosis can occur with different mental or physical health conditions, some medicines or substance use. It does not automatically mean schizophrenia. New symptoms need prompt professional assessment. itself.
How do I say the name?
Benztropine: BENZ-troe-peen. Capital letters show the stressed syllable.
Medicine forms and official information
Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.
Choose a formulation
Benztropine mesylate tablets
Oral tablets; other forms are not presumed interchangeable.
Benztropine mesylate injection
Clinician-administered intramuscular or intravenous product.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- Benztropine mesylate tablets: prescribing information — mechanism explanation
Scope: Mechanism explanation only. Source sections checked: Clinical Pharmacology; Indications; Precautions; Adverse Reactions..
- Benztropine: original FDA application and historical product status
- Benztropine: patient information — mechanism explanation
Scope: Mechanism explanation only. Source sections checked: Why is this medication prescribed?; Side effects..
- Benztropine mesylate: Hikma injectable product labeling
Scope: United States; foreign scientific and safety context only.
- DailyMed - BENZTROPINE MESYLATE tablet
- Benztropine: Package Insert / Prescribing Information
- Benztropine: selected generic FDA approval and product status
- An evidence-based update on anticholinergic use for drug-induced movement disorders
- Benztropine mesylate injection: FDA approval and status
- Benztropine: curated stereochemistry and database cross-reference caution
- Bolden, Cusack and Richelson: Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells — mechanism explanation
Scope: Mechanism explanation only. Source sections checked: Abstract: receptor-binding experiment..
- Tardive dyskinesia: MedlinePlus Medical Encyclopedia
- NIMH: Mental Health Medications
- A qualitative investigation into the effects of akathisia - Health Research Authority
- Extrapyramidal side effects- Management
- Anxiety and panic attacks - NHS
- Agitation: MedlinePlus Medical Encyclopedia
- NIMH: Understanding psychosis
Giving medicine safely to children: family guide (PDF, 3 pages)

